PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King\'s College London, London, UK.\', \'Health Data Research UK London, University College London, London, UK.\', \'NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\'s College London, London, UK.\', \'King\'s College Hospital NHS Foundation Trust, London, UK.\', \'School of Cardiovascular Medicine & Sciences, King\'s College London British Heart Foundation Centre of Excellence, London, UK.\', \'Institute of Health Informatics, University College London, London, UK.\', \'NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King\'s College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/ejhf.1924
?:hasPublicationType
?:journal
  • European journal of heart failure
is ?:pmid of
?:pmid
?:pmid
  • 32485082
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.784
?:rankingScore_hIndex
  • 114
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all